Phase II Trial of High-Dose Rituximab with Thiotepa/Busulfan/Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma

Autor:	Lakshmi Nayak, Jeffrey A. Barnes, Fred H. Hochberg, Karen K. Ballen, Mark Brezina, Tracy T. Batchelor, Candice Del Rio, Ephraim P. Hochberg, Yi Bin Chen, Jessica Driscoll, Steven L. McAfee, Ann S. LaCasce, Andrew S. Chi, SooAe Jones, Erin Coughlin, Philippe Armand, Amanda Duong
Rok vydání:	2013
Předmět:	Oncology medicine.medical_specialty Transplantation business.industry CNS Involvement ThioTEPA Hematology Autologous stem-cell transplantation Internal medicine Immunology medicine Hodgkin lymphoma Rituximab Busulfan/Cyclophosphamide business medicine.drug
Zdroj:	Biology of Blood and Marrow Transplantation. 19(2):S129-S130
ISSN:	1083-8791
DOI:	10.1016/j.bbmt.2012.11.063
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ed899b8c8aa0c5012a7960cc559339a Zobrazit plný text záznamu Full Text from ScienceDirect